Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04068818 · ClinicalTrials.gov registry record
The Heidelberg Engineering ANTERION Imaging Agreement Study
A clinical trial, sponsored by Heidelberg Engineering.
- Completed
- Registry status
- 87
- Enrollment target
NCT04068818: Completed study, sponsored by Heidelberg Engineering.
NCT04068818 is a clinical trial that has completed, run by Heidelberg Engineering. The registered enrollment target is 87 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04068818 has completed, sponsored by Heidelberg Engineering.
- COMPLETED
- Registry status
- 87 participants
- Enrollment target
Study Summary
This is a prospective clinical study that will be conducted at one clinical site located in the United States to assess image quality of acquired biometry images of the eye
Primary Outcome
Comparison of the B-Scan image quality between the ANTERION and the reference device
Interventions
- DEVICE ANTERION
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2019-08-22 |
| Est. Completion | 2021-04-27 |
What the finished NCT04068818 record still lists
NCT04068818 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 87 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which ANTERION is the first listed.
NCT04068818 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04068818 about?
NCT04068818 is a clinical study titled "The Heidelberg Engineering ANTERION Imaging Agreement Study". This is a prospective clinical study that will be conducted at one clinical site located in the United States to assess image quality of acquired biometry images of the eye
What is the current status of trial NCT04068818?
This trial is currently completed. The enrollment target is 87 participants. The study started on 2019-08-22. Estimated completion is 2021-04-27.
What interventions are being tested in trial NCT04068818?
The interventions under investigation include: ANTERION (DEVICE).
Who is sponsoring clinical trial NCT04068818?
This trial is sponsored by Heidelberg Engineering, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03292601 · 87 participants · NA
Brace Monitoring for Adolescent Idiopathic Scoliosis (AIS)
- NCT04291105 · 87 participants · Phase 2
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
- NCT04565795 · 87 participants · NA
Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy
- NCT05607004 · 87 participants · Phase 2
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI